logo
Share SHARE
FONT-SIZE Plus   Neg

Foundation Medicine And Clovis Oncology Enter Into Diagnostic Collaboration

Foundation Medicine Inc. and Clovis Oncology Inc. (CLVS) announced that they have entered into a diagnostic collaboration. The company said that the goal of the collaboration is to develop an in-vitro diagnostic or IVD to identify biomarkers to select cancer patients most likely to respond to Clovis' product candidate rucaparib, a poly (ADP-ribose) polymerase or PARP inhibitor currently in Phase I/II clinical development.

Clovis Oncology said that the company and Foundation Medicine will analyze the genomic alterations found in tissue samples from patients to evaluate the feasibility of developing an IVD method to identify patients who have tumors more likely to respond to rucaparib.

In particular, the goal of the collaboration is to identify the additional genetic mutations beyond those in germ-line and somatic BRCA that are associated with defective DNA repair and may define appropriate tumor targets for rucaparib.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Online travel agency Priceline Group, Inc. on Wednesday reported an increase in profit for the first quarter from last year on double-digit revenue growth amid higher travel and room night bookings. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. However, the company provided financial outlook for the second quarter below analysts' estimates. Time Warner Inc. (TWX) reported a profit for its first quarter ended March 31, 2016 that increased about 25 percent from the prior year. Revenues increased 3% and adjusted operating income grew 11% due to strong growth across all its operating divisions. It reaffirmed its 2016 adjusted earnings per share outlook. German telecom giant Deutsche Telekom AG reported Wednesday that its first-quarter net profit quadrupled on hefty stake sale gain. Revenues also increased on US strength, while domestic revenues were weak.
comments powered by Disqus
Follow RTT